ARTICLE | Company News
Modern Biosciences, University of Aberdeen deal
October 22, 2007 7:00 AM UTC
The university granted Modern Biosciences an exclusive, worldwide license to preclinical compounds to treat osteoporosis, rheumatoid arthritis (RA) and other inflammatory indications. The compounds ar...